Paola Grandi, PhD Birth Date - American Society of Gene & Cell ...

More documents

Recommendations

Info

Božac A., Berto E., Garrafa E., Gardo G., Boccafogli L., Xausa M., Gavioli R., GRANDI P., Manservigi R., Marconi P.C.(2002). Replication defective HSV-1 vectors - a novel anti-tat vaccination strategy. In: 7th European Conference onExperimental AIDS Research-ECEARGRANDI P., Wang S., Schuback D., Krasnykh V., Spear M., Curiel D., Manservigi R., Breakefield X (2002). HSV-1amplicon vector engineered for specific binding to pseudo His-tag receptor. MOLECULAR THERAPY, ISSN: 1525-0024Bozac A., Berto E., Garrafa E., Gardo G., Xausa M., Boccafogli L., Gavioli R., GRANDI P., Manservigi R., Marconi P.(2002). Vettori erpetici non replicativi – vaccini innovativi contro tat. . In: 10th Congresso Nazionale S.I.M.M.O.CGrandi P. HSV-1 amplicon vector engineered for specific binding to pseudo his-tag receptor. Boston, Neurosurgery Dept.8 January 2003Grandi P. Sequential localization of two Herpes simplex virus tegument proteins to puntcate nuclear dots adjacent to ICP0domains. Boston, Harvard Medical School, Molecular Neurogenetics Dept. 6 June 2003GRANDI P., Samuel Wang, Deborah Schuback, Victor Krasnykh, Matthew Spear, David Curiel, Roberto Manservigi,Xandra Breakefield (2003). Amplicon Vector Engineered for Specific Binding to Pseudo His-Tag Receptor. In:International Herpesvirus Workshop 2003. Madison (USA), 26-31 luglio 2003Grandi P. Binding of HSV-1 vectors to a specific cell surface receptor. Can we image the infection process in vivo?Boston, Harvard Medical School, Molecular Neurogenetics Dept. 12 March 2004Grandi P. Oncolytic vectors:new strategies of tumor retargeting and imaging. University of Ferrara, Italy, 17 May 2004GRANDI P., Trevor McKee, Juliet L. Fernandez, Rakesh K. Jain, Xandra Breakefield (2004). New strategy to improvetumor infectibility of HSV-1 vectors in vivo. In: International Herpesvirus Workshop 2004. Reno, Nevada, USA, July2004Oehmig, Schuback D., GRANDI P., Fraefel C., Breakefield X (2004). Delivery of AAV REP proteins as VP16-REPfusion proteins in HSV-1 virions. In: International Herpesvirus Workshop 2004. Reno (Nevada-USA), July 25 - Friday,July 30GRANDI P., Wang S, Schuback D, Krasnykh V, Spear M, Curiel DT, Manservigi R, Breakefield XO (2004). HSV-1virions engineered for specific binding to cell surface receptors. MOLECULAR THERAPY, ISSN: 1525-0016GRANDI P. (2004). Binding of HSV-1 vectors to a specific cell surface receptor. Can we image the infection process invivo? , Invited speaker. University of Zurich, SwitzerlandGrandi P. Novel strategies for enhanced cancer therapy using HSV vectors. University of Pittsburgh, 13 December 2004GRANDI P. (2005). Binding of HSV-1 vectors to New Strategy to Improve Imaging and Retargeting of HSV-1 Vectors,Invited Speaker.American Society of Gene, Therapy, St. Louis, MOGRANDI P., McKee T, Mok W, Fernandez J, Breakefield X, Jain RK (2005). New Strategy To Improve Imaging andRetargeting of HSV-1 Vectors . MOLECULAR THERAPY, ISSN: 1525-0024GRANDI P., Trevor McKee, Juliet L. Fernandez, Rakesh K. Jain, Xandra Breakefield (2005). In vivo imaging ofcollagnease-enhanced hsv oncolytic vector destruction of solid tumors. In: International Herpesvirus Workshop 2005Turku, Finland, 30th July- 4th August6
GRANDI P. (2005). In vivo imaging of collagnease-enhanced hsv oncolytic vector destruction of solid tumors. , Best Oralpresentation award: International Herpesvirus Workshop, Turku, FinlandTrevor McKee, GRANDI P., Wilson Mok George Alexandrakis Yves Boucher, Xandra O. Breakefield, Rakesh K. Jain(2005). Degradation of fibrillar collagen in solid tumors improves the efficacy of oncolytic viral therapy. In: BMES.baltimore, September 28 - October 1, 2005GRANDI P. (2006). Novel Strategies for enhancing Cancer Therapy using HSV Oncolytic Vectors. , Invited Speaker.Xi’an Jiaotong , University Medical School, ChinaGRANDI P. (2006). Novel Strategies for enhancing Cancer Therapy using HSV Oncolytic Vectors. . In: CancerMolecular Diagnosis and Gene Therapy International Symposium, 2006. Xi'an, China, 22-23 October 2006Li H, Krisky D, GRANDI P., Baskaran R, Glorioso J (2006). HSV-1 ICP0 enhance viral growth through activation ofChk2 nad Induction of G2 arrest. In: International Herpesvirus Workshop . Seattle, 22-28 July 2006GRANDI P., Fernadez J., Szemntirmai O., Carter R., Breakefield X., Sena- Esteves M (2006). Targeting HSV-1 virionsfor specific binding to Epidermal Growth Factor Receptro-vIII on Tumor cells. MOLECULAR THERAPY, ISSN: 1525-0024Glorioso JC, GRANDI P., Krisky D, Goins W, Goss J, Fink DF (2006). HSV gene vectors and treatment of chronic painand cancer. JOURNAL OF NEUROIMMUNOLOGY, ISSN: 0165-5728GRANDI P., Fernandez J, Szentirmai O, Carter R, Breakefield XO (2006). Targeting HSV-1 Virions for Specific Bindingto Epidermal Growth Factor Receptor-VIII on Tumor Cells. MOLECULAR THERAPY, ISSN: 1525-0024BOZAC A, BERTO E, VASQUEZ F, GRANDI P., CAPUTO A, MANSERVIGI R, ENSOLI B, P. MARCONI (2006).Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector inducesantigen-specific T cell responses. VACCINE, vol. 24(49-50); p. 7148-7158, ISSN: 0264-410XGRANDI P. (2007). Design and application of HSV oncolytic vectors for treatment of brain tumors, Invited SpeakerConference: Oncolytic Viruses as Cancer Therapeutics. The 4th International Conference (Arizona-USA), March 14-17,2007GRANDI P., Forero A., Niranjan A, Fellows W, Okada H, Klinkenberg D, Krisky D, Glorioso J. (2007). Design of ICP0Deficient HSV Oncolytic Vectors for Treatment of Glioblastoma. MOLECULAR THERAPY, ISSN: 1525-0016GRANDI P., Forero A, Niranjan A. Fellows, W., Goins W., Okada, H., Klinkenberg, D, Krisky, D. and Glorioso, JC.(2007). Role of IDO on HSV oncolytic vectors activity. JOURNAL OF NEUROVIROLOGY, ISSN: 1355-0284GRANDI P. (2007). Novel Strategies for Enhancing Cancer Therapy using HSV Oncolytic Vectors. , Invited Speaker:The Clinical Oncology Grand Rounds, UPCIGRANDI P., Forero A, Niranjan Fellows W, Goins W, Okada H, Klinkenberg D, Krisky D, Glorioso JC (2007). Designof ICP0 Deficient Oncolytic HSV vectors for treatment of Glioblastoma. In: IHW (International Herpesvirus Workshop).Asheville, North Carolina (USA) , July 7-12, 2007GRANDI P. (2007). New Oncolytic HSV vectors for treatment of Glioblastoma. , Invited Speaker. 10th ASGT. May 30-June 3, 2007, Seattle, Washington, USA.GRANDI P. (2007). Novel Strategies for Enhancing Cancer Therapy Using HSV Oncolytic Vectors , Invited Speaker.Korea Institue of Radiological and Medical Sciences November 29, 2007, Seoul, South Korea7
Page 1 and 2: CURRICULUM VITAEName: Paola Grandi,
Page 3 and 4: 11. Bozac, Berto E., VasquezF., Gra
Page 5: In this proposal, experiments are o
Page 9: Miyagawa Y, Cohen J, Simonato M, GR

Paola Grandi, PhD Birth Date - American Society of Gene & Cell ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?